US Pharma MarketingThe post Neuraptive secures exclusive licence from Washington University for nerve device appeared first on Medical Device Network.
Neuraptive secures exclusive licence from Washington University for nerve device
Neuraptive Therapeutics has secured an exclusive licence from Washington University in St. Louis for a bioresorbable wireless electronic stimulation device designed for peripheral nerve repair. The newly licensed device will be added to Neuraptive’s portfolio, which includes NTX-001, currently in Phase III clinical evaluation. Developed at Washington University with Northwestern, the technology delivers targeted electrical pulses to damaged nerves to support regeneration. Credit: totojang1977 / Shutterstock.com. Neuraptive Therapeutics has secured an exclusive licence from Washington University in St Louis for a bioresorbable wireless electronic stimulation device designed for peripheral nerve repair. The technology, which was developed at Washington University School…
Neuraptive Therapeutics has secured an exclusive licence from Washington University in St. Louis for a bioresorbable wireless electronic stimulation device designed for peripheral nerve repair.
Source: Medical Device Network